| Date Filed | Type | Description |
| 08/21/2023 |
4
| McKenna Mark C. (Director) has filed a Form 4 on Apogee Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $23.6, valued at
$1.2M
Granted 100,000 options to buy
@ $23.6, valued at
$2.4M
|
|
| 08/21/2023 |
3
| McKenna Mark C. (Director) has filed a Form 3 on Apogee Therapeutics, Inc. |
| 08/21/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/10/2023 |
SC 13G
| FMR LLC reports a 12.1% stake in APOGEE THERAPEUTICS INC |
| 08/07/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 07/28/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/24/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/21/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/17/2023 |
4
| Gottesdiener Andrew (Director) has filed a Form 4 on Apogee Therapeutics, Inc.|
Txns:
| Granted 47,758 options to buy
@ $17, valued at
$811.9k
|
|
| 07/17/2023 |
4
| Shah Nimish P (Director) has filed a Form 4 on Apogee Therapeutics, Inc.|
Txns:
| Bought 1,750,000 shares
@ $17, valued at
$29.8M
Granted 47,758 options to buy
@ $17, valued at
$811.9k
|
|
| 07/17/2023 |
4
| Fairmount Funds Management LLC (Director) has filed a Form 4 on Apogee Therapeutics, Inc.|
Txns:
| Bought 55,913 shares
@ $17, valued at
$950.5k
Bought 1,992,734 shares
@ $17, valued at
$33.9M
Bought 892,529 shares
@ $17, valued at
$15.2M
Granted 47,758 options to buy
@ $17, valued at
$811.9k
|
|
| 07/17/2023 |
3/A
| Dambkowski Carl (Chief Medical Officer) has filed a Form 3/A on Apogee Therapeutics, Inc. |
| 07/17/2023 |
3/A
| Henderson Jane (CFO) has filed a Form 3/A on Apogee Therapeutics, Inc. |
| 07/17/2023 |
3/A
| HENDERSON MICHAEL THOMAS (CEO) has filed a Form 3/A on Apogee Therapeutics, Inc. |
| 07/17/2023 |
3/A
| Fox Jennifer A. (Director) has filed a Form 3/A on Apogee Therapeutics, Inc. |
| 07/17/2023 |
3/A
| JONES WILLIAM A JR (Director) has filed a Form 3/A on Apogee Therapeutics, Inc. |
| 07/17/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 07/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/13/2023 |
3
| Dambkowski Carl (Chief Medical Officer) has filed a Form 3 on Apogee Therapeutics, Inc. |
| 07/13/2023 |
3
| Henderson Jane (CFO) has filed a Form 3 on Apogee Therapeutics, Inc. |
| 07/13/2023 |
3
| HENDERSON MICHAEL THOMAS (CEO) has filed a Form 3 on Apogee Therapeutics, Inc. |
| 07/13/2023 |
3
| Fox Jennifer A. (Director) has filed a Form 3 on Apogee Therapeutics, Inc. |
| 07/13/2023 |
3
| JONES WILLIAM A JR (Director) has filed a Form 3 on Apogee Therapeutics, Inc. |
| 07/13/2023 |
3
| Gottesdiener Andrew (Director) has filed a Form 3 on Apogee Therapeutics, Inc. |
| 07/13/2023 |
3
| Shah Nimish P (Director) has filed a Form 3 on Apogee Therapeutics, Inc. |
| 07/13/2023 |
3
| Fairmount Funds Management LLC (Director) has filed a Form 3 on Apogee Therapeutics, Inc. |
| 07/13/2023 |
S-1MEF
| Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]: |
| 07/12/2023 |
CERT
| Form CERT - Certification by an exchange approving securities for listing: |
| 07/10/2023 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |
| 07/10/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 07/03/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |